{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:51:26Z","timestamp":1783381886679,"version":"3.54.6"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2017-06962"],"award-info":[{"award-number":["RGPIN-2017-06962"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-159711"],"award-info":[{"award-number":["PJT-159711"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK076169"],"award-info":[{"award-number":["DK076169"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.psyneuen.2021.105149","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T11:48:37Z","timestamp":1611056917000},"page":"105149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Serum soluble epoxide hydrolase related oxylipins and major depression in patients with type 2 diabetes"],"prefix":"10.1016","volume":"126","author":[{"given":"Natasha Z.","family":"Anita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nubaira","family":"Forkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radia","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsi","family":"Major-Orfao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Lanct\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul I.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiju R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Assal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana J.","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa L.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameer Y.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Swardfager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2021.105149_bib1","doi-asserted-by":"crossref","unstructured":"Balasubramanian, G., Vas, P., Chockalingam, N., Naemi, R., 2020. A synoptic overview of neurovascular interactions in the foot. Front. Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2020.00308.","DOI":"10.3389\/fendo.2020.00308"},{"key":"10.1016\/j.psyneuen.2021.105149_bib2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","article-title":"Comparison of Beck depression inventories -IA and -II in psychiatric outpatients","volume":"67","author":"Beck","year":"1996","journal-title":"J. Pers. Assess."},{"key":"10.1016\/j.psyneuen.2021.105149_bib3","series-title":"Manual for the Beck Depression Inventory-II","author":"Beck","year":"1996"},{"key":"10.1016\/j.psyneuen.2021.105149_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.psyneuen.2016.04.002","article-title":"Mood and metabolism: anhedonia as a clinical target in type 2 diabetes","volume":"69","author":"Carter","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2021.105149_bib5","first-page":"1","article-title":"Blockade of soluble epoxide hydrolase attenuates post-ischemic neuronal hyperexcitation and confers resilience against stroke with TrkB activation","volume":"8","author":"Chang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psyneuen.2021.105149_bib6","series-title":"Psychodynamic Psychotherapy Research: Evidence-Based Practice and Practice-Based Evidence","first-page":"553","article-title":"Empirically informed clinical interviewing for personality disorders","author":"DeFife","year":"2012"},{"key":"10.1016\/j.psyneuen.2021.105149_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5483\/BMBRep.2016.49.3.268","article-title":"The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities","volume":"49","author":"Erion","year":"2016","journal-title":"BMB Rep."},{"issue":"18","key":"10.1016\/j.psyneuen.2021.105149_bib8","doi-asserted-by":"crossref","first-page":"14867","DOI":"10.1074\/jbc.M011761200","article-title":"Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition","volume":"276","author":"Fang","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.psyneuen.2021.105149_bib9","doi-asserted-by":"crossref","first-page":"H2412","DOI":"10.1152\/ajpheart.00527.2004","article-title":"Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels","volume":"287","author":"Fang","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.psyneuen.2021.105149_bib10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3945\/an.114.007732","article-title":"Advances in our understanding of oxylipins derived from dietary PUFAs","volume":"6","author":"Gabbs","year":"2015","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.psyneuen.2021.105149_bib11","doi-asserted-by":"crossref","first-page":"E3240","DOI":"10.1073\/pnas.1521453113","article-title":"CYP450-derived oxylipins mediate inflammatory resolution","volume":"113","author":"Gilroy","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psyneuen.2021.105149_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048852","article-title":"Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids","volume":"7","author":"Grapov","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2021.105149_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00036","article-title":"Role of soluble epoxide hydrolase in metabolism of PUFAs in psychiatric and neurological disorders","volume":"10","author":"Hashimoto","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.psyneuen.2021.105149_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.psychres.2017.02.056","article-title":"Altered soluble epoxide hydrolase-derived oxylipins in patients with seasonal major depression: An exploratory study","volume":"252","author":"Hennebelle","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2021.105149_bib15","first-page":"7","article-title":"Association between pro- and anti-inflammatory cytokines and depressive symptoms in patients with diabetes-potential differences by diabetes type and depression scores","author":"Herder","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105149_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108484","article-title":"Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: a review of recent studies","volume":"86","author":"Hildreth","year":"2020","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.psyneuen.2021.105149_bib17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature25013","article-title":"Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy","volume":"552","author":"Hu","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.psyneuen.2021.105149_bib18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1124\/dmd.115.063339","article-title":"The 2014 Bernard B. Brodie Award lecture - epoxide hydrolases: drug metabolism to therapeutics for chronic pain","volume":"43","author":"Kodani","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.psyneuen.2021.105149_bib19","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","article-title":"Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs","volume":"4","author":"Lakens","year":"2013","journal-title":"Front. Psychol."},{"key":"10.1016\/j.psyneuen.2021.105149_bib20","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3389\/fphys.2018.01047","article-title":"Food for mood: relevance of nutritional omega-3 fatty acids for depression and anxiety","volume":"9","author":"Larrieu","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.psyneuen.2021.105149_bib21","first-page":"300","article-title":"In vivo activity of epoxide hydrolase according to sequence variation affects the progression of human IgA nephropathy","author":"Lee","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.psyneuen.2021.105149_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cpp.693","article-title":"Inter-rater reliability of the structured clinical interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II)","volume":"18","author":"Lobbestael","year":"2011","journal-title":"Clin. Psychol. Psychother."},{"key":"10.1016\/j.psyneuen.2021.105149_bib23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nm0597-562","article-title":"Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase","volume":"3","author":"Moghaddam","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.psyneuen.2021.105149_bib24","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1111\/dme.12193","article-title":"The association between diabetes and an episode of depressive symptoms in the 2002 World Health Survey: an analysis of 231 797 individuals from 47 countries","volume":"30","author":"Mommersteeg","year":"2013","journal-title":"Diabet. Med."},{"key":"10.1016\/j.psyneuen.2021.105149_bib25","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1186\/1742-2094-10-142","article-title":"Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence","volume":"10","author":"Najjar","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.psyneuen.2021.105149_bib26","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1007\/s00125-010-1874-x","article-title":"Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis","volume":"53","author":"Nouwen","year":"2010","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.psyneuen.2021.105149_bib27","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1161\/STROKEAHA.120.031068","article-title":"Depression and diabetes mellitus multimorbidity is associated with loss of independence and dementia poststroke","volume":"51","author":"Ouk","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.psyneuen.2021.105149_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4093\/dmj.2015.39.5.353","article-title":"Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia","volume":"39","author":"Parhofer","year":"2015","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.psyneuen.2021.105149_bib29","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/j.celrep.2019.11.006","article-title":"Liver soluble epoxide hydrolase regulates behavioral and cellular effects of chronic stress","volume":"29","author":"Qin","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.psyneuen.2021.105149_bib30","series-title":"Progress in Molecular Biology and Translational Science","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/B978-0-12-800101-1.00008-9","article-title":"Free fatty acids and skeletal muscle insulin resistance","author":"Rachek","year":"2014"},{"key":"10.1016\/j.psyneuen.2021.105149_bib31","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/dme.13779","article-title":"WHO-5 and BDI-II are acceptable screening instruments for depression in people with diabetes","volume":"35","author":"Rauwerda","year":"2018","journal-title":"Diabet. Med."},{"key":"10.1016\/j.psyneuen.2021.105149_bib32","doi-asserted-by":"crossref","first-page":"E1944","DOI":"10.1073\/pnas.1601532113","article-title":"Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress","volume":"113","author":"Ren","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psyneuen.2021.105149_bib33","first-page":"9","article-title":"Deficiency of soluble epoxide hydrolase protects cardiac function impaired by LPS-induced acute inflammation","author":"Samokhvalov","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.psyneuen.2021.105149_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/609202","article-title":"Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus","volume":"2011","author":"Serlin","year":"2011","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"10.1016\/j.psyneuen.2021.105149_bib35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/mp.2015.26","article-title":"Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosa","volume":"21","author":"Shih","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2021.105149_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3233\/JAD-191197","article-title":"Oxidized products of omega-6 and omega-3 long chain fatty acids are associated with increased white matter hyperintensity and poorer executive function performance in a cohort of cognitively normal hypertensive older adults","volume":"74","author":"Shinto","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"4","key":"10.1016\/j.psyneuen.2021.105149_bib37","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.bbalip.2014.07.020","article-title":"Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism","volume":"1851","author":"Spector","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.psyneuen.2021.105149_bib38","article-title":"Assessment of soluble epoxide hydrolase activity in vivo","author":"Stefanovski","year":"2020","journal-title":"A Metab. Approach"},{"key":"10.1016\/j.psyneuen.2021.105149_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2018.01.010","article-title":"Metabolic\/inflammatory\/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target","volume":"87","author":"Swardfager","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psyneuen.2021.105149_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/FJC.0b013e318298e460","article-title":"Anti-inflammatory effects of \u03c9-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension","volume":"62","author":"Ulu","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.psyneuen.2021.105149_bib41","doi-asserted-by":"crossref","DOI":"10.2337\/dc07-0536","article-title":"Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics: Response to Fisher et al.","volume":"30","author":"Vale","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.psyneuen.2021.105149_bib42","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1523\/JNEUROSCI.3069-18.2019","article-title":"Astrocytic epoxyeicosatrienoic acid signaling in the medial prefrontal cortex modulates depressive-like behaviors","volume":"39","author":"Xiong","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2021.105149_bib43","doi-asserted-by":"crossref","unstructured":"Yanagida, K., Hla, T., 2017. A dark side to omega-3 fatty acids. Nature. https:\/\/doi.org\/10.1038\/d41586-017-07678-8.","DOI":"10.1038\/d41586-017-07678-8"},{"key":"10.1016\/j.psyneuen.2021.105149_bib44","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.1021\/ac901282n","article-title":"Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry","volume":"81","author":"Yang","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.psyneuen.2021.105149_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jnutbio.2017.07.006","article-title":"Postprandial effect to decrease soluble epoxide hydrolase activity: roles of insulin and gut microbiota","volume":"49","author":"Yang","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.psyneuen.2021.105149_bib46","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s12975-018-0672-5","article-title":"Soluble epoxide hydrolase-derived linoleic acid oxylipins in serum are associated with periventricular white matter hyperintensities and vascular cognitive impairment","volume":"10","author":"Yu","year":"2019","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.psyneuen.2021.105149_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jad.2020.03.070","article-title":"Increased expression of soluble epoxide hydrolase in the brain and liver from patients with major psychiatric disorders: a role of brain \u2013 liver axis","volume":"270","author":"Zhang","year":"2020","journal-title":"J. Affect. Disord."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453021000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453021000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:21:58Z","timestamp":1778512918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453021000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":47,"alternative-id":["S0306453021000238"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2021.105149","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum soluble epoxide hydrolase related oxylipins and major depression in patients with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2021.105149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105149"}}